LEMAITRE VASCULAR INC — Director's Dealing 2022

Dec 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2022-12-22

Reporting Person: Roberts David B (Director, President and Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-22	Common Stock	M	17	—	Acquired	16874	Direct
2022-12-22	Common Stock	F	132	$45.94	Disposed	16742	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-22	Dividend Equivalent Rights	$	M	17	Disposed		Common Stock (17)	Direct

Footnotes

F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F2: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

F3: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.